FOSL1 and central nervous system cancer: In line to what was observed in mouse glioma-initiating cells, FOSL1 silencing in MES BTSC 380 resulted in reduced cell growth (Figure 7C) with a significant reduction of the percentage of BrdU positive cells compared to Dox-untreated cells (Figure 7D).